The main target of miR-15/16 that has been identified is bcL2 (10), miR-15/16 triggers apoptosis by suppressing the expression of bcL2, but it also targets other oncogenes, such as cyclin D1, MCL1, CDC2, ETS1 and JUN, that are involved in cancer progression (9). Here, BCL2 is linked to cancer.